<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; encouraging</title>
	<atom:link href="http://www.tapanray.in/tag/encouraging/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>The Union Budget 2010-11…the issue of improving access to healthcare…encouraging innovation… and beyond</title>
		<link>http://www.tapanray.in/the-union-budget-2010-11the-issue-of-improving-access-to-healthcareencouraging-innovation-and-beyond/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=the-union-budget-2010-11the-issue-of-improving-access-to-healthcareencouraging-innovation-and-beyond</link>
		<comments>http://www.tapanray.in/the-union-budget-2010-11the-issue-of-improving-access-to-healthcareencouraging-innovation-and-beyond/#comments</comments>
		<pubDate>Mon, 08 Mar 2010 01:00:37 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[2010-11]]></category>
		<category><![CDATA[Access]]></category>
		<category><![CDATA[Affordability]]></category>
		<category><![CDATA[beyond]]></category>
		<category><![CDATA[Budget]]></category>
		<category><![CDATA[encouraging]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Improving]]></category>
		<category><![CDATA[incentive]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[issue]]></category>
		<category><![CDATA[of]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[to]]></category>
		<category><![CDATA[Union]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=458</guid>
		<description><![CDATA[The Primary role of the pharmaceutical industry in India, like in many other countries of the world, is to make significant contribution to the healthcare objectives of the nation by meeting the needs of the ailing patients through improved access &#8230; <a href="http://www.tapanray.in/the-union-budget-2010-11the-issue-of-improving-access-to-healthcareencouraging-innovation-and-beyond/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/the-union-budget-2010-11the-issue-of-improving-access-to-healthcareencouraging-innovation-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Recent Bayer Case Judgment: Patent Linkage: Encouraging Innovation in India</title>
		<link>http://www.tapanray.in/recent-bayer-case-judgment-patent-linkage-encouraging-innovation-in-india/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=recent-bayer-case-judgment-patent-linkage-encouraging-innovation-in-india</link>
		<comments>http://www.tapanray.in/recent-bayer-case-judgment-patent-linkage-encouraging-innovation-in-india/#comments</comments>
		<pubDate>Mon, 24 Aug 2009 00:30:40 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Bayer]]></category>
		<category><![CDATA[Case]]></category>
		<category><![CDATA[encouraging]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Judgment]]></category>
		<category><![CDATA[linkage]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=800</guid>
		<description><![CDATA[Delhi High Court turned down the request of Bayer Corporation in August 18, 2009 to link patent status of its kidney cancer drug Nexavar (sorefenib tosylate) with the marketing approval of the generic equivalent of the same patented molecule manufactured &#8230; <a href="http://www.tapanray.in/recent-bayer-case-judgment-patent-linkage-encouraging-innovation-in-india/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/recent-bayer-case-judgment-patent-linkage-encouraging-innovation-in-india/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
